Weitzel and Blazer win ASHG Arno Motulsky-Barton Childs Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Jeffrey N.Weitzel
Kathleen Blazer

City of Hope’s Jeffrey N. Weitzel and Kathleen Blazer are the 2019 recipients of the American Society of Human Genetics’ Arno Motulsky-Barton Childs Award for Excellence in Human Genetics Education.

Weitzel is Chief of the Division of Clinical Cancer Genomics and the Cancer Screening and Prevention Program at City of Hope. Blazer directs City of Hope’s Cancer Genomics Education Program.

This award recognizes individuals for contributions of exceptional quality and importance to human genetics education internationally. Awardees have had long-standing involvement in genetics education, producing diverse contributions of substantive influence on individuals and/or organizations.

Weitzel and Blazer will receive the award, including a plaque and monetary prize, during ASHG’s 69th Annual Meeting Oct. 15 in Houston.

Weitzel and Blazer have worked together for more than 20 years to provide innovative and impactful cancer genomics education to clinicians and researchers from diverse training backgrounds and practice settings across the United States and internationally. Their NCI-funded CGEP initiatives have ranged from educating primary care physicians for referral-level competence, to preparing master’s and doctoral clinicians for leadership in translational cancer genomics research.

Table of Contents

YOU MAY BE INTERESTED IN

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. ...

VOICES of Black Women, the largest population study of Black women in the United States, will be the first of American Cancer Society’s large-scale population studies to be initiated using an AI-driven data management platform—promising to bring observational cancer research out of the age of Excel data files and email sharing.

Login